Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like ams releases NanEyeM integrated Micro Camera Module (MCM) assembly November 7, 2018 Demonetisation: Cement production on course for first decline in 15 years March 5, 2017 Human Collaboration a Focus for New Grippers Across Industry June 22, 2018